[Treatment methods in chronic bronchitis].

[Interferon inhibition of the development of a staphylococcal infection]. Antibiot Med Biotekhnol (1985) 0.82

[Effect of interferon type I on the in vivo persistence of Salmonella typhimurium]. Zh Mikrobiol Epidemiol Immunobiol (1986) 0.81

[Effect of exogenous interferon and various interferon inducers on the indicators of general reactivity in systemic lupus erythematosus]. Ter Arkh (1980) 0.79

[Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients]. Zh Nevropatol Psikhiatr Im S S Korsakova (1987) 0.78

[Human leukocytic interferon as an agent for emergency prevention of influenza and other acute respiratory diseases in children's preschool institutions]. Pediatriia (1990) 0.78

[The role of adherent cells in supporting natural cytotoxicity reactions]. Biull Eksp Biol Med (1989) 0.77

Increased plasma endothelin levels in patients with insulin-dependent diabetes mellitus and end-stage vascular complications. Horm Metab Res (1994) 0.77

[A study of the production specifications for extracting leukocyte interferon]. Vopr Virusol (1969) 0.77

[Effect of levamisole on cellular immunity indices in chronic bronchitis and chronic pneumonia patients]. Ter Arkh (1984) 0.76

[The use of leukinferon in treating zoonotic cutaneous leishmaniasis. 2. Patient treatment]. Med Parazitol (Mosk) (1993) 0.76

[Common variable immunodeficiency in adults and problems of its immunotherapy]. Ter Arkh (1998) 0.75

[Data on the problem of use of interferon for the treatment and prevention of viral skin diseases]. Vestn Dermatol Venerol (1971) 0.75

[Study of migrative capacity of leukocytes in patients with rheumatism in autoculture. Phenomenon of spontaneous migration of leukocytes]. Ter Arkh (1975) 0.75

[Effect of human regulatory myelopeptides on the elaboration of a factor inhibiting leukocyte migration]. Biull Eksp Biol Med (1988) 0.75

[Experimental-clinical study of endogenous and exogenous interferons]. Antibiotiki (1967) 0.75

[Treatment of dermatoses of viral and non-viral etiology with interferon]. Vrach Delo (1974) 0.75

[Blast-transformation of lymphocytes in patients with rheumatic fever]. Ter Arkh (1972) 0.75

[Mechanism of synthesis of amphiphilic molecules under model prebiotic conditions]. Zh Evol Biokhim Fiziol (1977) 0.75

[Incidence, diagnosis, prevention and treatment of insulin allergy]. Vutr Boles (1988) 0.75

[Tobacco smoking and beta-cell secretion]. Vutr Boles (1991) 0.75

[Delayed hypersensitivity in rheumatism studied using human cardiac myosin]. Ter Arkh (1982) 0.75

[Inhibitor factors in the serum of patients with the AIDS-related complex]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75

[Use of immunodepressive cytostatic agents in rheumatology]. Sov Med (1971) 0.75

[Determination of cellular hypersensitivity of delayed type in patients with rheumatism by the method of leukocyte migration inhibition]. Vopr Revm (1975) 0.75

[Cellular immunity function in HIV-1-infected persons]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75

[Nature of new markers of general pathology]. Ter Arkh (2002) 0.75

[The isotope method for the determination of the nitrogen-fixing ability of oligonitrophilous bacteria]. Mikrobiol Zh (1972) 0.75

[High-degree obesity--a risk factor for the development of diabetes mellitus]. Vutr Boles (1990) 0.75

[Distribution of oligonitrophilous microorganisms in certain types of Ukrainian soil]. Mikrobiol Zh (1969) 0.75

[Nitrogen-fixing ability of oligonitrophils in soil and their role in soil enrichment by fixed nitrogen]. Mikrobiol Zh (1972) 0.75

[Study of cellular immunity indices in rheumatism]. Vopr Revm (1977) 0.75

[Autoimmune changes in various rheumatic diseases]. Ter Arkh (1986) 0.75

[Oligonitrophylic bacteria and their nitrogen fixation properties]. Mikrobiol Zh (1966) 0.75

[A comprehensive study of the phagocytic link in immunity in primary immunodeficiency states]. Zh Mikrobiol Epidemiol Immunobiol (1991) 0.75

[Use of the rosette formation method for evaluation of the T- and B immunity systems in rheumatic fever]. Ter Arkh (1978) 0.75

[Elastase and acid phosphatase activity in bronchoalveolar lavage fluid during chronic bronchitis]. Biull Eksp Biol Med (1990) 0.75

[Clinical trial of domestic drug polyoxidonium in secondary immunodeficiency]. Ter Arkh (1998) 0.75

[New approach to detection of the minimal activity of rheumatism]. Ter Arkh (1974) 0.75

[The clinical course of influenza in patients treated with interferon and symptomatic agents]. Klin Med (Mosk) (1973) 0.75

[Comparative evaluation of method of drug therapy for rheumatism]. Ter Arkh (1966) 0.75

[The pathogenetic aspects of immunodeficiency states with a predominant disorder of the humoral link of immunity (a review)]. Ter Arkh (1997) 0.75

[The action of low-intensity laser radiation on the immune system]. Ter Arkh (1992) 0.75

[Clinical efficacy of a Minidiab preparation (glipizide) in an acute experiment]. Vutr Boles (1988) 0.75

[Effect of different sources of nitrogen nutrition on the morphological characteristics of oligonitrophils]. Mikrobiol Zh (1972) 0.75

[Study of the photoprotective properties of a new cosmetic cream "Kvant"]. Vestn Dermatol Venerol (1986) 0.75

[The cytological characteristics of bronchoalveolar washings in chronic bronchitis]. Probl Tuberk (1989) 0.75

[Diagnostic value of antigens of cell membranes of the myocardium for detection of the activity of rheumatic process]. Vopr Revm (1976) 0.75

[A trial of the use of the new Russian preparation oxymetacil in patients with chronic nonspecific lung diseases]. Ter Arkh (1995) 0.75

[Treatment of psoriasis with human leukocyte interferon and interferon combined with deoxyribonuclease and cytostatics (preliminary report)]. Vestn Dermatol Venerol (1972) 0.75

[Immunodiagnosis and immunotherapy of chronic nonspecific lung diseases]. Ter Arkh (1985) 0.75

[New approaches to the study of immunodeficiency states in chronic nonspecific lung diseases]. Ter Arkh (1991) 0.75

[Study on the effect of antirheumatic therapy on the indices of the leukocyte migration inhibition test using myocardial cell membrane antigens in patients with rheumatism]. Ter Arkh (1977) 0.75

[Possibility of transferring patients with type-II diabetes mellitus treated with small doses of sulfonylurea preparations to diet therapy]. Vutr Boles (1987) 0.75

[Peculiarities of allergy in rheumatism]. Klin Med (Mosk) (1966) 0.75

[The relationship of HLA antigens to certain clinical forms of diabetes mellitus]. Vutr Boles (1989) 0.75

[Treatment of persistently unhealing wounds and trophic ulcers with interferon ointment]. Vestn Khir Im I I Grek (1972) 0.75

[Comparison between humoral and cellular immune response to antigen of Streptococcus group A cytoplasm in patients with rheumatism]. Ter Arkh (1978) 0.75

[Lymphocyte migration inhibition reaction indices using myocardial cell membrane antigens in children with rheumatism]. Vopr Revm (1980) 0.75

[The clinico-immunological evaluation of the ribomunyl treatment of chronic bronchitis patients]. Ter Arkh (1994) 0.75

[Comparison of the body's reactions to the constant and intermittent action of some chlorinated hydrocarbons]. Gig Tr Prof Zabol (1976) 0.75

[The role of immune mechanisms in the pathogenesis of chronic bronchopulmonary pathology]. Ter Arkh (1987) 0.75

[Myocardium-sensitized lymphocytes in myocardial infarction]. Ter Arkh (1981) 0.75

[The state of cellular immunity in patients with systemic scleroderma]. Ter Arkh (1987) 0.75

[Reaction of the leukocyte migration inhibition in response to cardiac antigens in patients with rheumatism]. Sov Med (1974) 0.75

[Differential diagnosis of tonsillitis-derived lesions of the heart and rheumocarditis]. Sov Med (1972) 0.75

[Cellular immunity indices in the dynamics of rheumatism according to leukocyte migration inhibition reaction data]. Vopr Revm (1979) 0.75

[The immunomodulating action of extracorporeal treatment methods and the late effect from their use in patients with rheumatoid arthritis]. Ter Arkh (1992) 0.75

[T- and B-systems of immunity in rheumatic fever]. Ter Arkh (1979) 0.75

[An improvement in insulin efficacy in patients with type-1 diabetes mellitus following treatment using an insulin infusion pump]. Vutr Boles (1989) 0.75

[Comparative study of blood and urine seromucoid proteins in healthy persons and in patients with rheumatism]. Vrach Delo (1971) 0.75

[A study of the nitrogen-fixing ability of oligonitrophylic microorganisms by the isotopic method]. Mikrobiol Zh (1969) 0.75

[Immunologic methods of diagnosing rheumatism]. Ter Arkh (1982) 0.75

[Effect of antihypertensive drugs on insulin secretion and efficacy]. Vutr Boles (1989) 0.75

[Factors affecting stability in the course of insulin-dependent diabetes mellitus]. Vutr Boles (1989) 0.75

[Immunogenetic studies in patients with pneumoconiosis]. Ter Arkh (1991) 0.75

[The possibilities of using immunological indices as criteria for determining the stage of HIV infection and the disease prognosis]. Vestn Ross Akad Med Nauk (1992) 0.75

[Laboratory markers of the reactogenicity of smallpox vaccines]. Vopr Virusol (1972) 0.75

[Efficacy of myelopid in immunodeficiency states]. Ter Arkh (1990) 0.75

Regional differences in diabetic patients' pharmacotherapy in Bulgaria. Eur Rev Med Pharmacol Sci (2014) 0.75

[Insulin secretion and action in acromegaly]. Vutr Boles (1987) 0.75

[Study of immunology of rheumatism]. Vestn Akad Med Nauk SSSR (1967) 0.75

[Determination of benzene in blood]. Gig Sanit (1978) 0.75

[Lysogeny and Bac. megaterium bacteriophage]. Mikrobiol Zh (1969) 0.75

[The clinico-immunological efficacy of the likopid treatment of chronic bronchitis patients]. Ter Arkh (1998) 0.75

[Study of methods of stimulating interferon formation]. Vopr Virusol (1974) 0.75

[Impaired manifestations of human genetics in pathology and perspectives of improvement in the treatment of diseases of various etiology]. Ter Arkh (2004) 0.75

[Role of free-living nitrogen fixers in the nitrogen balance of soils]. Mikrobiol Zh (1978) 0.75

[T- and B-system immunity study of rheumatism patients]. Vopr Revm (1978) 0.75

[Characteristics of the set-up of the lymphocyte blast transformation reaction using whole blood]. Lab Delo (1990) 0.75

[Oligonitrophilic differences in Mycococcus albus]. Mikrobiol Zh (1971) 0.75

[The immune status in different clinical forms of insulin-dependent diabetes mellitus]. Ter Arkh (1993) 0.75

[The toxicokinetic characteristics of benzene for assessing the degree of its harmful action]. Gig Tr Prof Zabol (1985) 0.75

[Study of delayed type allergy in rheumatism]. Vopr Revm (1970) 0.75

[Cytokine effects on generation of oxygen active forms by lung and peripheral blood phagocytes]. Biull Eksp Biol Med (1998) 0.75

[Cyproterone acetate improves beta-cell function in postmenopausal women with diabetes mellitus type 2]. Akush Ginekol (Sofiia) (2003) 0.75

[Prospects for the use of the myocardial cell membrane antigens for diagnosis of the degree of activity of rheumatism]. Sov Med (1978) 0.75

[Clinical efficiency of various intermittent plasmapheresis regimens in patients with rheumatoid arthritis (according to data of two clinics]. Ter Arkh (1989) 0.75

[An attachment for Ilizarov's device for repositioning fresh fractures of long tubular bones]. Ortop Travmatol Protez (1970) 0.75

[Use of interferon in prophylaxis and treatment of acute respiratory viral infections in children]. Vopr Okhr Materin Det (1970) 0.75

[Effectiveness of using diucifon in patients with chronic pulmonary pathology]. Ter Arkh (1986) 0.75